Kingsley Leung
Presidente presso UNI-BIO SCIENCE GROUP LIMITED
Patrimonio netto: 18 M $ in data 30/04/2024
Posizioni attive di Kingsley Leung
Società | Posizione | Inizio | Fine |
---|---|---|---|
UNI-BIO SCIENCE GROUP LIMITED | Presidente | 13/01/2017 | - |
Direttore/Membro del Consiglio | 28/02/2014 | 13/01/2017 | |
The Hong Kong Society of Financial Analysts | Corporate Officer/Principal | - | - |
The Hong Kong Institute of Directors
The Hong Kong Institute of Directors Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Directors operates as premier body which represents professional directors. The company was founded by Moses Cheng in 1997 and is headquartered in Hong Kong. | Corporate Officer/Principal | - | - |
Greater Bay Capital Ltd.
Greater Bay Capital Ltd. Financial ConglomeratesFinance Greater Bay Capital Ltd. operates as an investment holding company. The company is headquartered in British Virgin Islands. | Direttore/Membro del Consiglio | - | - |
Great Bay Bio Holdings Ltd.
Great Bay Bio Holdings Ltd. Packaged SoftwareTechnology Services Great Bay Bio Holdings Ltd. is a high-tech enterprise based in China that specializes in applying artificial intelligence and other cutting-edge technologies in CMC bioprocessing. The Chinese company aims to solve numerous pain-points of the biopharmaceutical industry, including high failure rates, long development timelines, and high costs. Great Bay Bio has accumulated massive bioprocessing development data from its 3100 m2 CMC facility and has successfully brought a number of biologic products to NDA stage. The company has created an intelligent centralized database where deep learning is being performed to create a next-generation, all-encompassing AI-enabled bioprocessing ecosystem. Great Bay Bio is headquartered in China and was founded in 2019 by Kingsley Leung and Michael Chen, who has been the CEO since incorporation. | Presidente | - | - |
Fondatore | - | - |
Storia della carriera di Kingsley Leung
Precedenti posizioni note di Kingsley Leung
Società | Posizione | Inizio | Fine |
---|---|---|---|
Young Innovation & Development Alliance | Corporate Officer/Principal | - | - |
Federation of Hong Kong Industries | Corporate Officer/Principal | - | - |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Corporate Officer/Principal | - | - |
Formazione di Kingsley Leung
Imperial College London | Undergraduate Degree |
University of Oxford | Graduate Degree |
Statistiche
Distribuzione geografica
Hong Kong | 7 |
Regno Unito | 3 |
Singapore | 2 |
Posizioni
Corporate Officer/Principal | 5 |
Director/Board Member | 2 |
Chairman | 2 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
UNI-BIO SCIENCE GROUP LIMITED | Health Technology |
Aziende private | 7 |
---|---|
The Hong Kong Society of Financial Analysts | |
The Hong Kong Institute of Directors
The Hong Kong Institute of Directors Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Directors operates as premier body which represents professional directors. The company was founded by Moses Cheng in 1997 and is headquartered in Hong Kong. | Commercial Services |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
Greater Bay Capital Ltd.
Greater Bay Capital Ltd. Financial ConglomeratesFinance Greater Bay Capital Ltd. operates as an investment holding company. The company is headquartered in British Virgin Islands. | Finance |
Young Innovation & Development Alliance | |
Great Bay Bio Holdings Ltd.
Great Bay Bio Holdings Ltd. Packaged SoftwareTechnology Services Great Bay Bio Holdings Ltd. is a high-tech enterprise based in China that specializes in applying artificial intelligence and other cutting-edge technologies in CMC bioprocessing. The Chinese company aims to solve numerous pain-points of the biopharmaceutical industry, including high failure rates, long development timelines, and high costs. Great Bay Bio has accumulated massive bioprocessing development data from its 3100 m2 CMC facility and has successfully brought a number of biologic products to NDA stage. The company has created an intelligent centralized database where deep learning is being performed to create a next-generation, all-encompassing AI-enabled bioprocessing ecosystem. Great Bay Bio is headquartered in China and was founded in 2019 by Kingsley Leung and Michael Chen, who has been the CEO since incorporation. | Technology Services |
Federation of Hong Kong Industries |
- Borsa valori
- Insiders
- Kingsley Leung
- Esperienza